Literature DB >> 7462292

Tumor host relations. IV. Tissue distribution of citric acid cycle intermediates and of glutamate in tumor-bearing rats high level of alpha-ketoglutarate in solid Yoshida sarcomas.

W Schreibmayer, R J Schaur, H M Tillian, E Schauenstein, K Hagmüller.   

Abstract

To elucidate the origin of increased concentrations of alpha-ketoglutarate (KG) in tumor bearers the tissue distribution of KG together with the related metabolites citrate, succinate, malate, and glutamate was determined in tumor, liver, gastrocnemius muscle, and blood of rats bearing the solid Yoshida sarcoma and of tumor-free rats. The sum of these metabolites was significantly increased in host liver and blood, respectively, compared with the corresponding tissues of normal rats. Among single metabolites glutamate and malate were significantly increased in host liver. The absolute concentrations were highest in host liver with the exception of KG, which was highest in the tumor. This was taken as indicative for the tumor as the prime source of increased KG in blood of tumor-bearers. No significant metabolic deviations were found in gastrocnemius muscle. The concentration of KG in this muscle of both normal and host animals correlated significantly with that of glutamate. In the tumor the concentration of KG correlated significantly with that of citrate plus succinate plus malate. This type of correlation was absent in liver and muscle of both normal and host animals. Moreover, no correlation existed between KG and glutamate either in liver or in tumor. It was suggested that the metabolic flux through the citric cycle determines the concentration of KG in the tumor.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7462292     DOI: 10.1007/bf00409899

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  3 in total

1.  Tumor host relations. II. Increase of alpha-ketoglutarate in whole blood and urine and hypoalbuminemia of rats bearing the solid rhabdomyosarcoma BA 1112 and the ascitic or solid forms of Walker-carcinoma 256 and Yoshida-sarcoma.

Authors:  R J Schaur; W Schreibmayer; H J Semmelrock; H M Tillian; E Schauenstein
Journal:  J Cancer Res Clin Oncol       Date:  1979-04-12       Impact factor: 4.553

2.  [The blood levels of alpha-ketoglutaric acid at the various stages of the carcinoma of the cervix of the uterus (author's transl)].

Authors:  M Binder; R Winter
Journal:  Arch Gynakol       Date:  1973

3.  [Alpha-ketoglutaric acid increase in the blood and the localization and histology of malignant tumors].

Authors:  L Kronberger; E Fink
Journal:  Med Klin       Date:  1969-12-05
  3 in total
  3 in total

1.  [Regression of Yoshida sarcoma during normoxia and hypoxia after fractionated irradiation].

Authors:  V Strnad; F Kamprad; J Jahns; M Meyer; R Böhme; P Madaj-Sterba; M Kirschner; R Sauer
Journal:  Strahlenther Onkol       Date:  1997-03       Impact factor: 3.621

2.  Tumor host relations. V. Nitrogen metabolism in Yoshida sarcoma-bearing rats. Reduction of growth rate and increase of survival time by administration of physiological doses of branched-chain amino acids.

Authors:  R J Schaur; H J Semmelrock; W Schreibmayer; H M Tillian; E Schauenstein
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

3.  Tumor host relations. VI. Is alpha-ketoglutarate a tumor marker? Association with tumor extent in humans--correlation with tumor size in rats.

Authors:  L Kronberger; H J Semmelrock; R J Schaur; E Schauenstein; W Schreibmayer; E Fink
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.